Two distinctive antinociceptive systems in rats with pathological pain

Neuroscience Letters

Volumn 280, Issue 1, 2000, Pages 13-16

  Mao, J ^a   Price, D D ^b   Lu, J ^c   Keniston, L ^c   Mayer, D J ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Antinociception; Cannabinoids; Morphine; Pathological pain

Indexed keywords

CANNABINOID RECEPTOR; DIZOCILPINE; DRONABINOL; MORPHINE; NALOXONE; OPIATE RECEPTOR; RIMONABANT;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; CROSS TOLERANCE; DOSE RESPONSE; DRUG EFFECT; HYPERALGESIA; MALE; NERVE INJURY; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT;

ANALGESICS, NON-NARCOTIC; ANIMALS; CANNABINOIDS; DIZOCILPINE MALEATE; DRUG TOLERANCE; HEAT; HYPERALGESIA; INJECTIONS, SPINAL; MALE; MORPHINE; NALOXONE; PIPERIDINES; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; REACTION TIME; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; SCIATIC NERVE; TETRAHYDROCANNABINOL;

EID: 0033956629     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00998-2     Document Type: Article

References (18)

1. Arner S., Meyerson B.A. Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain. 33:1988;11-23.
2. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
3. Hampson A.J., Bornheim L.M., Scanziana M., Yost C.S., Gray A.T., Hansen B.M., Leonoudakis D.J., Bickler P.E. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission. J. Neurochem. 70:1998;671-676.
4. Herzberg U., Eliav E., Bennett G.J., Kopin I.J. The analgesic effect of R(+)-Win 55,212-2 mesylate, a high affinity cannabinoid agonist, in a rat model of neuropathic pain. Neurosci. Lett. 221:1997;157-160.
5. Jadad A.R., Carroll D., Glynn C.J., Moore R.A., McQuay H.J. Morphine responsiveness of chronic pain: double-blind randomized crossover study with patient-controlled analgesia. Lancet. 339:1992;1367-1371.
6. Lichtman A.H., Martin B.R. Spinal and supraspinal mechanisms of cannabinoid-induced antinociception. J. Pharmacol. Exp. Ther. 258:1991;517-523.
7. Mao J., Price D.D., Mayer D.J. Experimental mononeuropathy reduces the antinociceptive effects of morphine: implications for common intracellular mechanisms involved in morphine tolerance and neuropathic pain. Pain. 61:1995;353-364.
8. Mao J., Price D.D., Mayer D.J. Mechanisms of hyperalgesia and opiate tolerance: a current view of their possible interactions. Pain. 62:1995;259-274.
9. Ossipov M.H., Lopez Y., Nichols M.L., Bian D., Porreca F. The loss of antinociceptive efficacy of spinal morphine in rats with nerve ligation injury is prevented by reducing spinal afferent drive. Neurosci. Lett. 199:1995;87-90.
10. Reche I., Fuentes J.A., Ruiz-Gayo M. Potentiation of delta-9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of mu- and kappa-opioid receptors. Eur. J. Pharmacol. 318:1996;11-16.
11. Richardson J.D., Aanonsen L., Hargreaves K.M. SR141716A, a cannabinoid receptor antagonist, produces hyperalgesia in untreated mice. Eur. J. Pharmacol. 319:1997;R3-R4.
12. Richardson J.D., Aanonsen L., Hargreaves K.M. Hypoactivity of the spinal cannabinoid system results in NMDA-dependent hyperalgesia. J. Neurosci. 18:1998;451-457.
13. Robino T., Tizzoni L., Vigano D., Massi P., Parolaro D. Modulation of rat brain cannabinoid receptors after chronic morphine treatment. NeuroReport. 8:1997;3219-3223.
14. Russo E. Cannabis for migraine treatment: the once and future prescription? An historical and scientific review. Pain. 76:1998;3-8.
15. Smith F.L., Cichewicz D., Martin Z.L., Welch S.P. The enhancement of morphine antinociception in mice by delta-9 tetrahydrocannabinol. Pharmacol. Biochem. Behav. 60:1998;559-566.
16. Smith P.B., Martin R.B. Spinal mechanisms of delta-9 tetrahydrocannabinol-induced analgesia. Brain Res. 578:1992;8-12.
17. Strangman N.M., Patrick S.L., Hohmann A.G., Tsou K., Walker J.M. Evidence for a role of endogenous cannabinoids in the modulation of acute and chronic pain sensitivity. Brain Res. 813:1998;323-328.
18. Welch S.P., Stevens D.L. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice. J. Pharmacol. Exp. Ther. 262:1992;10-18.